3rd Department of Pediatrics, School of Medicine, Aristotle University, Thessaloniki, Greece.
Eur J Pediatr. 2013 Apr;172(4):563-7. doi: 10.1007/s00431-012-1811-8. Epub 2012 Aug 21.
Extensively drug-resistant (XDR) tuberculosis (TB) represents a serious and growing problem in both endemic and non-endemic countries. We describe a 2.5-year-old girl with XDR-pulmonary TB and an 18-month-old boy with pre-XDR-central nervous system TB. Patients received individualized treatment with second-line anti-TB agents based on genotypic and phenotypic drug susceptibility testing results. Both children achieved culture conversion 3 months and 1 month after treatment initiation, respectively. The child with XDR-pulmonary TB showed evidence of cure while treatment adverse events were managed without treatment interruption. The child with pre-XDR-central nervous system TB after 6-month hospitalization with multiple infectious complications had a dismal end due to hepatic insufficiency possibly related to anti-TB treatment. This is the first report of children with pre-XDR and XDR TB in Greece, emphasizing the public health dimensions and management complexity of XDR TB.
广泛耐药性(XDR)结核病(TB)在流行和非流行国家都是一个严重且日益严重的问题。我们描述了一例 2.5 岁患有 XDR-肺部 TB 的女孩和一例 18 个月患有预 XDR-中枢神经系统 TB 的男孩。根据基因型和表型药物敏感性测试结果,患者接受了二线抗 TB 药物的个体化治疗。两名儿童在治疗开始后 3 个月和 1 个月分别实现了培养转换。患有 XDR-肺部 TB 的儿童显示出治愈的迹象,而治疗不良反应则在不中断治疗的情况下得到了处理。患有预 XDR-中枢神经系统 TB 的儿童在因多重感染并发症住院 6 个月后,因可能与抗 TB 治疗相关的肝功能不全而导致预后不良。这是希腊首例儿童预 XDR 和 XDR TB 的报告,强调了 XDR TB 的公共卫生层面和管理复杂性。